Ophthalmology

Ophthalmology is the monthly clinical journal of the American Academy of Ophthalmology, launched in January 1978 out of the Academy's sectional Transactions and produced by Elsevier, carrying a 2025 impact factor of 10.9 and ranking 2 of 98 titles in the Ophthalmology category of the SCIE.《眼科学》（Ophthalmology）是美国眼科学会（American Academy of Ophthalmology）的官方月刊，1978年1月由该会的分科年会报告集改组而来，现由（Elsevier）出版，2025年影响因子为10.9，在眼科学类别的98种期刊中列第2位并属Q1区

Scope

• The stated aim is to serve society by publishing clinical and basic science research and other relevant manuscripts that relate to the sense of sight, with excellence pursued through unbiased peer-review, the advancement of innovation and discovery, and the promotion of lifelong learning.办刊宗旨为发表与视觉有关的临床与基础研究及其他相关稿件以服务社会，并以公正的同行评审、推动创新与发现、促进终身学习来追求卓越
• The publisher presents the title as the leading clinical journal in its field and the National Library of Medicine indexes it under the single broad subject term Ophthalmology, so ocular and visual system work of every kind is in scope rather than one subspecialty.出版方把它定位为眼科学领域首屈一指的临床期刊，美国国家医学图书馆只给它挂眼科学这一个主题词，因此眼球与视觉系统各方向的研究都在收录之列而不限于某一亚专科
• Coverage described for authors runs from original clinical and basic science investigations to new diagnostic and surgical techniques, treatment methods, instrument updates, new drug findings and the results of clinical trials, alongside major reviews of defined topics.面向作者说明的收录范围包括原创临床与基础研究、新的诊断与手术技术、治疗方法、器械更新、新药发现与临床试验结果，并刊出围绕特定主题的重大综述
• The official guide for authors sorts submissions into a standard Manuscript type, an AAO Meeting Paper built on material presented at an Academy annual meeting, Correspondence from readers on articles posted online within the previous six months, and Editorials normally invited by the Editor-in-Chief or a section editor.官方作者指南把来稿分为标准稿件（Manuscript）、依据学会年会宣读材料撰写的会议论文（AAO Meeting Paper）、读者针对网上刊出六个月以内文章所写的通讯（Correspondence），以及通常由主编或栏目编辑约写的社论（Editorial）
• The journal claims right of first refusal on material presented at the Academy's annual meetings, so the newest ophthalmic trial and surgical results are steered into this title before any other outlet.该刊对学会年会宣读的材料主张优先发表权，使最新的眼科试验与手术结果先于其他平台在此刊出
• Narrower niches are carried by sister titles of the same family, with Ophthalmology Retina from 2017 and the gold open access Ophthalmology Science from 2021, which leaves Ophthalmology as the general comprehensive clinical organ of the Academy.更细的亚专科内容由同族姊妹刊承担，即2017年创刊的（Ophthalmology Retina）与2021年创刊的金色开放获取刊（Ophthalmology Science），本刊因此是学会的综合性临床会刊
• A standing disclaimer makes clear that statements and opinions are those of the authors and not necessarily those of the Academy or the publisher, and that the Academy endorses no company, drug or product.刊物常设声明指出所载观点属于作者而非必然代表学会或出版方，学会也不为任何企业、药品或产品背书

History

• Volume 85 number 1 appeared in January 1978 and the twelve monthly issues of that year opened with a short notice by Stanley M. Truhlsen titled Revision of Transactions, because the new monthly inherited the odd volume numbers of the sectional Transactions that had closed at volume 83 in November and December 1977.第85卷第1期于1978年1月出书，当年12期月刊以（Stanley M. Truhlsen）撰写的短文《报告集的改组》（Revision of Transactions）开篇，因为这份月刊直接承接分科报告集只出单数的卷号，而该报告集已在1977年11至12月合刊出到第83卷^[1]
• The Academy behind it grew from the American Academy of Ophthalmology and Otolaryngology, founded in 1896 to give continuing education to eye, ear, nose and throat doctors, and the two specialties parted when that parent body divided into separate academies in 1979.主办学会由1896年创立的美国眼科与耳鼻喉科学会（American Academy of Ophthalmology and Otolaryngology）演化而来，该会初为眼科与耳鼻喉科医师提供继续教育，1979年按专科分立两会，眼科单独注册为独立机构
• The library record traces the documentary line in three stages, the Academy Bulletin of November 1932 to December 1940, the combined Transactions of 1940 to 1974 and the Section on Ophthalmology volumes of 1975 to 1977, each carrying its own ISSN before the 1978 reform.馆方书目把这份刊的文献链分为三段，即1932年11月至1940年12月的学会公报、1940至1974年的眼耳鼻喉合科报告集、1975至1977年的眼科分科报告集，三段在1978年改组前各有独立ISSN
• Imprints moved from the Academy's own office at Rochester in Minnesota to the New York house Elsevier from the year 2000, while volume numbering kept alternating with the journal Otolaryngology, which began in the same month of January 1978 at volume 86.出版署名从学会设在明尼苏达州罗切斯特的自办编辑部转为自2000年起由纽约的（Elsevier）承办，卷号则一直与同在1978年1月创刊、起编为第86卷的《耳鼻喉科学》（Otolaryngology）交替编排
• An annual Instrument and book supplement has accompanied the volumes since 1981, the journal has been fully indexed in MEDLINE and Index Medicus from volume 85 number 1, and its text is carried online through the publisher's science platform.自1981年卷起每年附出一期仪器与图书增刊（Instrument and book supplement），该刊自第85卷第1期起被MEDLINE与（Index Medicus）完整收录，正文另经出版方的科学平台在线提供
• Its journal impact factor stood at 12.079 for 2021 and 14.277 for 2022, eased to 9.5 for 2024 and returned to 10.9 for 2025, holding Q1 status throughout.其影响因子在2021年为12.079、2022年为14.277，2024年回落至9.5，2025年回升到10.9，期间始终位居Q1区

Editors

• The current Editor-in-Chief is Russell N. Van Gelder, listed by the publisher as based in Seattle in Washington state and working in the Department of Ophthalmology of the University of Washington School of Medicine.现任主编为（Russell N. Van Gelder），出版方期刊页注明其驻地为华盛顿州西雅图，其本职单位是（University of Washington School of Medicine）眼科系
• His field is the eye's non-visual photoreception, the opsins and intrinsically photosensitive retinal ganglion cells of the mammalian retina, together with intraocular inflammation, and his papers carry the university's retina center and its departments of laboratory medicine and neurobiology as addresses.他的研究领域是眼的非视觉感光，即哺乳动物视网膜的非视觉视蛋白与内在光敏神经节细胞，兼及眼内炎症，其论文署名单位还包括该校视网膜中心与检验医学、神经生物学等系
• He had already written the title's year-end column under the masthead role of Curator-in-Chief in December 2022, the function attached to its clinical image material, before being placed on the publisher page as Editor-in-Chief.他在2022年12月即以馆藏总策展人（Curator-in-Chief）名义为该刊撰写年终专栏，这一职务掌管刊上的临床影像内容，此后他被出版方页面列为主编（Editor-in-Chief）^[2]
• All submissions pass external peer review overseen by the editors, and the title is one of seven ophthalmology, optometry and vision science journals whose editors-in-chief, with the director of the National Eye Institute, created the Council of Vision Editors Fellowship in 2024 to train early-career reviewers and future board members.所有来稿都经编辑主持的外部同行评审，该刊与另外6本眼科、验光学与视觉科学期刊的主编及美国国家眼科研究所所长在2024年共同创设视觉编辑理事会研究员项目（Council of Vision Editors Fellowship），用以训练早期职业评审人与后备编委^[3]
• The Academy reported in its 2025 review that its family of journals had already trained fifteen mentees in peer review and editorial practice through that fellowship, so the reviewer pool feeding this title is being widened on purpose.学会在2025年度回顾中称，其期刊家族已通过该研究员项目训练15名学员掌握同行评审与编辑实务，为该刊储备评审力量的做法被有意制度化
• Manuscripts enter through the Editorial Manager site the publisher keeps for the title at editorialmanager.com/OPHTHA and also reached from the Academy's journal homepage, and the guide for authors states that communication about manuscripts runs primarily by email and only with corresponding authors.来稿经出版方为该刊设置的（Editorial Manager）投审稿站点递交，地址为（editorialmanager.com/OPHTHA）并可从学会期刊主页进入，官方作者指南说明编辑部就稿件的沟通主要依靠电子邮件且只与通讯作者进行
• The publisher's journal page reports a review speed of 35 days, keeps the subscription route free of any publication charge to authors, and prices the author-paid open access route at 4990 US dollars before tax.出版方期刊页标注审稿速度为35天，订阅路径不向作者收取任何发表费，作者自费的开放获取路径定价4990美元且不含税